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Summary
Available information on periodontal diseases are numerous, ambiguous and for the 
most part highly specialised.
Through the years most of the research was focused on the microbiological aspects of 
the periodontitis. It has been noticed that bacteria alone are not sufficient for the initiation 
of periodontal diseases, although they play an important part in the process. Host respon-
se, smoking, stress and other risk factors influence the appearance of the disease, and the 
susceptibility to aggressive forms of periodontitis is genetically determined.
This knowledge brought significant changes to the concept of etiology, prevention and 
the treatment of periodontal diseases.
There is a huge amount of data on the bacterial role in the initiation of periodontal poc-
kets,  changes in the junctional epithelium, destruction of periodontal ligament and resorpti-
on of the alveolar bone. The bacteria play an indirect role in the tissue destruction, through 
activation of the host response which becomes pathological. It  seems hard to believe that 
the same host response factors are responsible both for the defence, as well as the appea-
rance of the disease. Therefore one of the basic questions that can be asked today is why 
isn’t the periodontal disease self –limiting in its nature, or why doesn’t it stop spontaniously.
The studies done in the last years are trying to explain this phenomenon by means of 
molecular and cellular regulatory mechanisms.
The studies using multi-variate analysis indicate that the bacterial components partici-
pate in the disease expression with a relatively low percentage. Host response factors are at 
least as, if not more important in the initiation of periodontitis. The complex interaction of 
the bacterial challenge and native and acquired immunity determine the final outcome of 
the disease.
Progress in understanding the molecular basics of the disease in the last decade has led 
to a better understanding of the process of the disease.
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INTRODUCTION
Available information on periodontal diseases are numerous, ambiguous and 
for the most part highly specialised. Through the years most of the research was 
focused on the microbiological aspects of the periodontitis. It has been noticed that 
bacteria alone are not sufficient for the initiation of periodontal diseases, althou-
gh they play an important part in the process. Host response, smoking, stress and 
other risk factors influence the appearance of the disease, and the susceptibility to 
aggressive forms of periodontitis is genetically determined. This knowledge brou-
ght significant changes to the concept of etiology, prevention and the treatment of 
periodontal diseases.
RECENT ADVANCES IN PERIODONTOLOGY
Periodontal diseases, including gingivitis and periodontitis, are the most 
commonly occuring, yet very specific infections, due to the unique anatomical feau-
tures of periodontal structures and the nature of pathogenic plaque biofilm disease. 
Periodontitis remains a major cause of tooth loss in adults, and presents a major pu-
blic health problem worldwide [1]. Periodontal diseases not only significantly affect 
oral health, but are increasingly recognised as serious infections with profound 
effects on general health in association with systemic diseases and disorders, such 
as cardiovascular diseases, cerebral stroke, diabetes, preterm birth and aspiration 
pneumonia [2-4]. Systemic diseases associated with oral biofilm belong to the group 
of diseases that present highest costs of treatment for the public health, which is 
another important factor contributing to the importance of proper understanding 
of etiology and progression of periodontal diseases and their prevention which has 
great value for oral and general health [5].
Over the past years, most of the research was focused on the microbiological 
aspects of the periodontitis. It has been noticed that bacteria alone are not suffici-
ent for the initiation of periodontal diseases, although they play an important role 
in the process. Host response, smoking, stress and other risk factors influence the 
presence of disease, and the susceptibility to aggressive periodontitis is genetically 
determined [6,7].
The bacteria play an indirect role in the tissue destruction, through activation 
of the host response which becomes pathological. It  seems hard to believe that the 
same host response factors are responsible both for the defence, as well as the appe-
arance of the disease. Therefore one of the basic questions that can be asked today is 
why isn’t the periodontal disease self –limiting in its nature, or why doesn’t it stop 
spontainously.
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Substantial progress has been achieved in understanding the etiology and pat-
hogenesis of periodontal diseases, including recognition of dental plaque as bio-
films, appreciation of the importance of host-microbe symbiosis, and understanding 
of the crucial role of host susceptibility in initiation and development of diseases, 
as well as great importance of innate immunity in the maintenance of periodontal 
homeostasis. We will give a brief account of the current scientific concepts of plaque 
biofilms, host response and host-biofilm interactions, as well as new therapeutic 
strategies.
It is estimated that at least 1014 bacterial commensals of various species reside 
on the surface of skin, teeth, dentures, the mucosal epithelial lining of the respira-
tory, gastrointestinal and urinary tracts. Bacteria form about 90% of all cells in our 
organisms, and their mass is calculated at 1-2 kilograms of the full body weight. 
What amazes is the fact that most of these bacteria, and bacterial interactions with 
the host are not pathogenic in nature and do not activate the immune system [8]. It 
has been shown that a large number of oral bacterial species are not detectable using 
traditional culture methods.
Last couple of years, new methods of sequencing whole microbial communities 
using 16s ribosomal RNA, called „high-throughput methods“ were developed [9]. 
They allow for the sequencing of whole genomes of specific bacteria, or identifica-
tion and sequencing of completely unknown phyla or species, as well as study of 
complete genomes and metabolic activities of complete microbial communities [10]. 
They can be used to discover gene activations responsible for bacterial pathogeni-
city. Genomic sequencing has revealed extreme variability of clone genomes in any 
given species, which stresses the importance of individual genes encoding virulen-
ce factors, and not only the presence and levels of certain species [11]. 
Predominant Gram positive bacteria were consistently found, not Gram nega-
tive like the numerous textbooks claim. The mistake stems from earliest studies, as 
later has been shown that mature Gram positive bacteria colour variably or negative 
[12].
Periodontitis has a polymicrobial etiology within the framework of a complex 
microbial ecosystem. With advances in sequencing technologies, comprehensive 
studies to elucidate bacterial community differences have recently become possible. 
81% of sequences could be mapped to cultivated species. 
Human Oral Microbiome Genome Project was started in 2009. The goal is sequ-
encing of the complete genetic code. Gram positive bacteria are predominant. Aro-
und 700 species and 35000 clones were found. Huge number of bacterial species 
are not native to oral cavity (thousands). Even methanogenic members of Archaea 
domain were found. Most of the oral bacteria belong to the following 11 phyla: Ac-
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tinobacteria, Bacteroidetes, Chloroflexi, Firmicutes, Fusobacteria, Proteobacteria, 
Spirochaetes, Synergistetes, Tenericutes and unnamed TM7 and SR11. Members of 
Firmicutes are the most frequent bacteria and include streptococci [8].
Kumar et al. [13] analysed the differences between health- and periodontitis-
associated bacterial communities, and analysis showed distinct community profiles 
in health and disease. Community diversity was higher in disease, and 123 species 
were identified that were significantly more abundant in disease, and 53 in health. 
Spirochaetes, Synergistetes and Bacteroidetes were more abundant in disease, whe-
reas the Proteobacteria were found at higher levels in healthy controls. Within the 
phylum Firmicutes, the class Bacilli was health-associated, whereas the Clostridia, 
Negativicutes and Erysipelotrichia were associated with disease. Elucidation of the-
se differences in community composition provides a basis for further understan-
ding the pathogenesis of periodontitis.
In another study the peri-implant microbiome was shown to differ significantly 
from the periodontal community in both health and disease. Peri-implantitis is a 
microbially heterogeneous infection with predominantly gram-negative species, 
and is less complex than periodontitis [14].
Significant association with periodontitis was found for Synergistetes (Deferri-
bacteres) D084 i BH017, Bacteroidetes AU126, Division SR1 (OP11) X112, Division 
TM7 I025 and known species Anaeroglobus geminatus, Eubacterium saphenum, 
P. endodontalis, P. denticola and Cryptobacterium curtum. With P gingivalis, T. 
denticola and T. forsythia, P. tannerae, F. alocis and P. endodontalis were related 
with the disease [15]. New molecular ecology techniques have widened the scope of 
knowledge of subgingival species and possible importance of uncultivable bacteria.
The studies using multi-variate analysis indicate that the bacterial components 
participate in the disease expression with a relatively low percentage. Host response 
factors are at least as, if not more important in the initiation of periodontitis [16]. The 
complex interaction of the bacterial challenge and native and acquired immunity 
determine the final outcome of the disease.
Progress in appreciating the molecular basics of the disease in the last decade 
has led to a better understanding of the disease process.
Genetic susceptibility to aggressive and chronic forms of periodontitis is well 
known. Studies on familie have shown the prevalence of familial aggregation to be 
40-50%, while in some families the prevalence was found to be up to 65% [17]. Seve-
ral genetic  predespositions for development/more severe disease were discovered 
[18]. According to studies on twins, 38-82% of disease variance is due to genetic 
factors [19], while the specific bacterial components are responsible for 9-16% of va-
riance in periodontitis.
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Consensus of the 7th European Workshop on Periodontology  that took place 
last year had following conclusions. Current preventive and treatment approaches 
are only partially effective, and this appears due to the therapeutic focus remaining 
primarily upon biofilm management rather than embracing a pivotal role for in-
flammation as a driver of biofilm composition as well as tissue damage [20]. 
Periodontitis remains a major public health issue and current management 
approaches have failed to impact upon the most high-risk proportion of the popula-
tion and those with the most severe disease. 
There is a need to develop new, more effective, and efficient preventive and tre-
atment approaches for gingivitis and periodontitis, which embrace recent advances 
in understanding of host modulation and inflammation resolution, as well as direct 
management of the microbiota.
Focus is maintained on the development of new therapeutic approaches, based 
on the understanding of host response modulation and resolution of disease, as well 
as on the direct access to microbial community [21].
Neutrophils are main cells of the innate immunity. They are responsible for the 
phagocytosis of microorganisms, form a protective wall stoping invasion of bacteria 
under the pocket epithelium. It was considered that abnormal function which leads 
to wrong inflammatory response is the central mechanism of disease progression, 
or that hyperactive neutrophil is the agent of destruction. Now it seems that nor-
mally activated neutrophils accumulate and persist in the tissues, without being 
able to resolve bacterial invasion  and lead to tissue destruction [22]. Sophsticated 
approach would aim at promoting the inflammation resolution by inducing apopto-
sis of neutrophils in the periodontium. The goal is to find substances that can limit 
the tissue destruction, but without impairment of the antimicrobial activity. Last 
years natural lipid agonists, resolvins, were linked to active induction of persistent 
inflammation resolution and lead to disappearance of clinical inflammation. Ne-
ucalcin, new molecule blocks TNFa induced raised levels of intracellular calcium, 
but does not block degranulation or activation after bacterial phagocytosis or influ-
ence bactericidal activity [23]. Although precise mode of action is unknown, such 
approaches that differentiate inflammation from bactericidal activity can lead to 
development of new therapeutics for controlling the pathways of persistent perio-
dontal inflammation [24].
Obesity influences innate and acquired immune response, and is characterised 
by changed systemic inflammatory response brought by disbalance in the cytokine 
network, raised levels of acute phase proteins and proinflammatory cytokines, like 
tumor necrosis factor and leukocytes in the plasma of obese persons [25,26]. If a 
hyperinflammatory state exists in the alimenatry induced obesity remains contro-
versial [27]. Obesity in clinical studies is linked to periodontitis [28,29].
Rad 514 Medical Sciences, 38(2012) : 49-59
A. Aurer: Modern understanding of periodontal diseases
54
Obesity raises the susceptibility to infection and postoperative complications 
[30]. It seems that high lipid diet disrupts normal immune response to P. gingiva-
lis. Repeated P. gingivalis  bacteraemias result in repeated endothelial/macrophage 
invasion which causes chronic inflammatory state, exacerbates atherosclerosis and 
periodontitis through homotolerance induction [31]. Tolerance induction is respon-
sible for the role of obesity in the faster progression of periodontal diseases [32].
The aim of immune host response modulation is to achieve clinical benefits out 
of understanding the host response mechanisms. New concepts in the treatment 
make use of natural pathways for inflammation inhibition as well as activation 
of healing and regeneration.  Inhibition or modification of inflammatory/immune 
response is strived for, using different mechanisms implementing substances like 
antimicrobial peptides, probiotics, antiinflammatory lipid mediators and micronu-
trients [33]. Good example of a succesful immunomodulatory implementation is 
treatment of rheumatoid arthritis, where targeted inhibition of inflammatory me-
diators led to succesful development of several therapeutics [34].
A variety of treatment strategies have been developed to target the host res-
ponse to periodontal infection. Matrix metalloproteinase inhibitors, such as low-
dose formulations of doxycycline, have been used in combination with scaling and 
root planing or surgical therapy. In addition, high-risk patient populations, such 
as patients with diabetes, have benefited from systemic matrix metalloproteinase 
administration. Encouraging results have been shown using soluble antagonists of 
tumor necrosis factor and interleukin-1 delivered locally to periodontal tissues in 
non-human primates, as well as more recent evidence using gene therapy vectors to 
provide a longer-term delivery of receptor antagonists at the periodontium [35,36]. 
Other therapeutic strategies being explored are aimed at inhibiting signal tran-
sduction pathways involved in inflammation. Pharmacological inhibitors of NF-κB 
and p38 MAPK pathways are actively being developed to manage rheumatoid ar-
thritis and inflammatory bone diseases. Using this novel strategy, inflammatory 
mediators, including pro-inflammatory cytokines (interleukin-1, tumor necrosis 
factor, interleukin-6), matrix metalloproteinases and others, would be inhibited at 
the level of cell-signaling pathways required for transcription factor activation nece-
ssary for inflammatory gene expression [37]. These therapies may provide the next 
generation of disease-specific chemotherapeutics to manage chronic periodontitis. 
Currently developed therapeutics have a significant, albeit clinically rather limited 
effect [38].
Resolution of iflammation can be understood as a stop for inflammatory signa-
ling processes. Disturbance of inflammation resolution, with overactivation of in-
flammatory response, plays a role in initiation and progression of periodontal de-
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struction. Proresolving lipid mediators have been described: lipoxins and resolvins. 
Diseases like periodontitis, asthma or rheumatoid arthritis have similar pathogenic 
mechanisms, with the constant activation of chronic processes that finally leads to 
tissue destruction [39]. 
In fact, new data suggest that the inflammatory response (gingivitis) might actu-
ally precede the emergence and overgrowth of periodontal pathogens in the biofilm. 
Moreover, new data suggest that failure of resolution of inflammation pathways 
may play as important a role in disease as overproduction of proinflammatory me-
diators. 
Experiments in animals and humans suggest an exciting new approach to the 
pharmacologic modulation of inflammation in disease: the use of receptor agonists 
of resolution of inflammation to actively regulate the inflammatory response. The 
same lipid mediators that drive resolution of inflammation enhance microbial clea-
rance at mucosal surfaces and improve bacterial clearance in infection [40].
In addition, the use of lipoxins has demonstrated significant potential in the ma-
nagement of host response to periodontitis [40]. Docosahexaenoic acid is example of 
such a molecule, whose action has been confirmed in experimental studies.
Use of live probiotic cultures for propagation of healthy microflora is a relati-
vely new concept. There is evidence that probiotics can influence the composition of 
microflora, and to a lesser degree the outcome of periodontal therapy [41]. It seems 
that the action is temporary, or continuous administration is needed for the effect to 
remain long-term. The data point to possibility of manipulation of oral microflora, 
or to a lesser degree periodontal health, either through direct microbial interactions, 
or by immunomodulatory interactions. 
Due to limited value of available studies, it is difficult to confirm clinical impor-
tance of such statistically significant  findings. Another question is should specific 
oral probiotics be developed for use, or the general probiotics suffice. Effects of pro-
biotic bacteria on the periodontal condition (plaque index,gingivitis index, bleeding 
on probing, PPD) are much more limited in magnitude when compared with the 
studies reporting on microbiological outcomes [41].
Nutritional modulation of periodontal inflammation is still at an early stage and 
relatively little is known about the influence of micronutrients on the progressi-
on of disease or response to therapy. It is known that high calorie intake induces 
inflammation [42], and obesity is linked to periodontitis [43]. Raised sugar intake 
increases gingival bleeding, and lowered intake of antioxidants and omega-3 fatty 
acids raises the disease prevalence [44]. The plasma of patients with periodontitis 
showed lowered levels of vitamins C, D, calcium and magnesium. Potentially bene-
ficient influence of additional nutritional therapeutical approaches by supplemen-
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ting vitamins C and D, omega-3 fatty acids, Ca and Mg and lowering the sugar 
intake [45,46].
CONCLUSION
Advanced microbiological methods will offer a clearer understanding of the bio-
film functioning as an ecosystem and help identify new periodontal pathogens. The 
knowledge of host response and modifiying factors can help in the future treatment 
of periodontal diseases and development of new preventive measures. Further de-
velopments of biological approaches in the periodontal therapy are expected.
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Sažetak
Suvremene spoznaje o parodontnim bolestima
Dostupne informacije  o parodontitisu su raznovrsne, brojne i velikim dijelom visoko 
specijalizirane.
Tijekom godina većina istraživanja bila je usmjerena na infekcijski aspekt parodontitisa. 
Uočeno je da bakterije nisu dostatne, iako su bitne u nastanku parodontitisa. Obrambene 
snage organizma, pušenje, stres i drugi faktori rizika bitno utječu na pojavu bolesti, pri čemu 
je genetski determinirana sklonost za agresivne oblike parodontitisa.
Ove spoznaje dovele su do značajnih promjena u koncepciji etiologije, prevencije i 
liječenja parodontnih bolesti.
Veliki je broj podataka o tome kako bakterije djeluju na nastanak parodontnih džepova, 
promjenu spojnog epitela, destrukciju ligamenata i resorpciju alveolne kosti. Razaranje tkiva 
bakterije izazivaju indirektno, aktiviranjem faktora obrane domaćina, čije djelovanje postaje 
patološko. Čini se nevjerojatnim da isti faktori domaćina uzrokuju obranu, ali i pojavu bo-
lesti. Stoga je pitanje, zašto se proces parodontne bolesti spontano ne zaustavi, jedno od 
temeljnih pitanja, koje danas postavljamo i na koje valja odgovoriti.
Istraživanja vršena posljednjih godina pokušavaju pomoću molekularnih i staničnih re-
gulacijskih mehanizama objasniti ovaj fenomen.
Studije prilagođene multivarijatnim analizama pokazuju da bakterijske komponente su-
djeluju u ispoljavanju bolesti u relativno malom postotku. Faktori domaćina su jednako, ako 
ne i više značajni u nastanku parodontitisa. Kompleksna interakcija bakterijskog izazova, te 
prirođeni i stečeni faktori domaćina determiniraju konačni ishod bolesti.
Napredak u poznavanju molekularnih osnova bolesti u posljednjem je desetljeću doveo 
do boljeg razumijevanja procesa bolesti.
Ključne riječi: periodontitis; oral microbiome; host response; immunomodula-
tion.
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